Back to Browse Journals » Energy and Emission Control Technologies » Volume 2

In-depth review of atmospheric mercury: sources, transformations, and potential sinks

Authors Gaffney JS, Marley NA

Received 18 March 2014

Accepted for publication 13 May 2014

Published 6 August 2014 Volume 2014:2 Pages 1—21

DOI https://dx.doi.org/10.2147/EECT.S37038

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Video abstract presented by Jeffrey S Gaffney

Views: 131

Jeffrey S Gaffney, Nancy A Marley

Department of Chemistry, University of Arkansas at Little Rock, Little Rock, AK, USA

Abstract: Mercury is a toxic heavy metal that is found naturally throughout the global environment. During the last 100 years, there has been a 70% rise in atmospheric mercury levels over the natural background measured prior to industrialization due to anthropogenic emissions. This increase in mercury levels represents a global threat to the health of ecosystems and humans worldwide. Atmospheric mercury chemistry is complex and its sources and sinks involve equilibrium interactions between the atmosphere, the hydrosphere, and the geosphere. This review outlines the fundamental chemistry of mercury in gas, aqueous, and solid phases, including inorganic, organic, and complexed mercury species. An understanding of this chemistry is important for understanding the cycling between the various environmental compartments as it affects atmospheric loadings. Further, many of these reactions can also occur in the atmosphere in heterogeneous gas/cloud/aerosol interactions. The sources and fate of mercury in the atmosphere, including the cycling of mercury through soil and water as it impacts atmospheric loadings are therefore examined. The sources of major uncertainties in our understanding of mercury in the atmosphere are also discussed, along with recommendations for future studies that include both homogeneous and heterogeneous reactions of the various mercury species.

Keywords: atmospheric mercury, mercury emission sources, mercury reactions, mercury speciation, atmospheric removal

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Frequency of medication errors in an emergency department of a large teaching hospital in southern Iran

Vazin A, Zamani Z, Hatam N

Drug, Healthcare and Patient Safety 2014, 6:179-184

Published Date: 11 December 2014

GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer

Zhang X, Huang M, Wu X, Kadlubar S, Lin J, Yu X, Fan C, Ning B, Kadlubar FF

Pharmacogenomics and Personalized Medicine 2013, 6:9-17

Published Date: 1 March 2013

Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries

Gudmundsson G, Ulrik CS, Gislason T, Lindberg E, Brøndum E, Bakke P, Janson C

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:571-576

Published Date: 14 September 2012

Update on neuromyelitis optica: natural history and management

Jindahra P, Plant GT

Eye and Brain 2012, 4:27-41

Published Date: 28 March 2012

A patient with mexiletine-related psychosis

Shailesh F, Singla S, Sureddi R, Deshmukh AJ, Paydak H

International Journal of General Medicine 2011, 4:765-766

Published Date: 2 November 2011

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Jain S, Diefenbach C, Zain J, O'Connor OA

Core Evidence 2011, 6:43-57

Published Date: 4 April 2011

TNF-α inhibitors: are they carcinogenic?

αGirindra Raval, Paulette Mehta

Drug, Healthcare and Patient Safety 2010, 2:241-247

Published Date: 6 December 2010

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

R Michael Kirchner, J Dawn Abbott

Vascular Health and Risk Management 2009, 5:1089-1097

Published Date: 16 December 2009